Patch-based Wound Healing Market Size to Grow by USD 329.13 million, Evolving Opportunities with 3M Co. and B. Braun SE - Technavio
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- The patch-based wound healing market will be driven by factors such as the increasing demand for advanced wound healing products. Healing chronic wounds take a lot of time, and they are more expensive to treat. However, modern wound care solutions are highly effective and efficient. The demand for advanced wound care products is increasing owing to the rise in rate of chronic injuries. For example, alginates and silver-containing advanced wound care products are used for draining excess fluid from wounds and shielding them from infections. These products have chemicals that can lead to quick healing and encourage cell proliferation.
The patch-based wound healing market size is expected to grow by USD 329.13 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 4.8% during the forecast period.
Delayed diagnosis of advanced and chronic wounds is challenging the growth of the market. Delayed diagnosis and treatment can worsen chronic wounds. The rate of delayed diagnosis is generally higher in emerging countries such as Brazil, China, and India. This is due to a lack of regulations and action plans by governing authorities, inadequate access to well-developed healthcare infrastructure, and a lack of awareness among communities. These factors reduce diagnosis rates, which limits the adoption of patch-based wound healing products in emerging countries.
Key Vendors and their Offerings
3M Co., Advancis Medical, Axio Biosolutions Pvt Ltd, B. Braun SE, CliniMed Ltd, Coloplast AS, ConvaTec Group Plc, Essity Aktiebolag, Harro Hofliger GmbH, Healogics LLC, Integra Lifesciences Holdings Corp., Lohmann and Rauscher GmbH and Co. KG, Medipurpose Pvt. Ltd., Mediq, Medline Industries Inc., Medtronic Plc, Ostomed Ltd., Paul Hartmann AG, Richardson Healthcare Inc., Smith and Nephew plc, among others, are the main players in the market. The key offerings of a few of these vendors are listed below:
3M Co. - The company offers patch-based wound healing methods such as 3M Prevena therapy, 3M Tegaderm, 3M Veraflo therapy, and others.
B. Braun SE - The company offers wound care with silver dressings such as Askina, Calgitrol, and others, which are intended to manage bioburden in acute and chronic wounds. Silver is used in various forms in wound dressings.
Coloplast AS - The company offers Biatain fiber as a patch-based wound healing solution, which is a fiber dressing with absorbent gel.
ConvaTec Group Plc - The company offers patch-based wound healing products such as Aquacel, DuoDERM, and Kaltostat.
Essity Aktiebolag - The company offers Cutimed, which is developed for the management of chronic and complex wounds. The Cutimed advanced wound care range reliably covers all stages of the healing process.
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 43%
Key consumer countries
US, Canada, Germany, UK, and China
Competitive landscape
Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled
3M Co., Advancis Medical, Axio Biosolutions Pvt Ltd, B. Braun SE, CliniMed Ltd, Coloplast AS, ConvaTec Group Plc, Essity Aktiebolag, Harro Hofliger GmbH, Healogics LLC, Integra Lifesciences Holdings Corp., Lohmann and Rauscher GmbH and Co. KG, Medipurpose Pvt. Ltd., Mediq, Medline Industries Inc., Medtronic Plc, Ostomed Ltd., Paul Hartmann AG, Richardson Healthcare Inc., and Smith and Nephew plc
Market dynamics
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Exhibit 115: Medline Industries Inc. - Product / Service
Exhibit 116: Medline Industries Inc. - Key offerings
10.10 Medtronic Plc
Exhibit 117: Medtronic Plc - Overview
Exhibit 118: Medtronic Plc - Business segments
Exhibit 119: Medtronic Plc - Key news
Exhibit 120: Medtronic Plc - Key offerings
Exhibit 121: Medtronic Plc - Segment focus
10.11 Paul Hartmann AG
Exhibit 122: Paul Hartmann AG - Overview
Exhibit 123: Paul Hartmann AG - Business segments
Exhibit 124: Paul Hartmann AG - Key offerings
Exhibit 125: Paul Hartmann AG - Segment focus
10.12 Smith and Nephew plc
Exhibit 126: Smith and Nephew plc - Overview
Exhibit 127: Smith and Nephew plc - Business segments
Exhibit 128: Smith and Nephew plc - Key news
Exhibit 129: Smith and Nephew plc - Key offerings
Exhibit 130: Smith and Nephew plc - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 131: Inclusions checklist
Exhibit 132: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 133: Currency conversion rates for US$
11.4 Research methodology
Exhibit 134: Research methodology
Exhibit 135: Validation techniques employed for market sizing
Exhibit 136: Information sources
11.5 List of abbreviations
Exhibit 137: List of abbreviations
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
The global urinary catheters market size is estimated to grow by USD 2.44 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 7.63% during the forecast period. ...
Zai Lab Limited and Innoviva Specialty Therapeutics today announced that China's National Medical Products Administration (NMPA) has approved Zai Lab's New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of...
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company"). This action, captioned Hope v. agilon health, inc., et...
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market. The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...